We hypothesize that the rapid progressive nature of anti-GBM disease, which often leads to ESKD within weeks, creates a pathological context distinct from the chronic models (e.g., diabetic kidney disease, unilateral ureteral obstruction) where the pro-fibrotic role of MMP-9 is well-established (37–40). This evidence concerns the gene MMP9 and diabetic kidney disease.